Photodynamic Therapy in Treating Patients With Skin Cancer

Completed · Phase 2

Conditions studied: Non-melanomatous Skin Cancer, Precancerous Condition

In brief

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy using aminolevulinic acid may be effective in treating patients with skin cancer. PURPOSE: This randomized phase II trial is studying how well photodynamic therapy that includes aminolevulinic acid works in treating patients with skin cancer.

Key facts

Study ID

NCT00002975

Run by

Roswell Park Cancer Institute

People needed

180

Starts

1997-02-01

Expected to finish

2010-04-01

Last updated by the study team

2013-10-10

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Roswell Park Cancer Institute — Buffalo, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.